A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Part of paid clinical trials in Mission Hills, California.
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Study ID
- NCT07501702
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Myasthenia Gravis, Generalized
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Povetacicept — DRUGSolution for Subcutaneous Injection.
- Placebo — DRUGSolution for Subcutaneous Injection.
Study Details
The purpose of this study is to evaluate the pharmacodynamic (PD) effect, safety, and tolerability of Povetacicept in participants with generalized myasthenia gravis (gMG).
Key Dates
- First listed
- Mar 30, 2026
- Start date
- May 13, 2026
- Status verified
- Jul 2026
- Primary completion
- Mar 2, 2029
- Completion
- Mar 2, 2029
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: PovetaciceptParticipants will be randomized to receive one of the two doses of povetacicept for the initial 12 weeks. Eligible participants can receive povetacicept for an additional 96 weeks.
- Placebo Comparator: PlaceboParticipants will be randomized to receive placebo matched to povetacicept for the initial 12 weeks. Eligible participants can receive povetacicept for an additional 96 weeks.
Primary Outcome Measure
Percent change in Total Immunoglobulin G (IgG) [ Time Frame: Baseline and At Week 12 ]
Central Contacts
- Medical Information617-341-6777
Locations (15)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Tri Valley Neurology Medical Associates Inc. | Mission Hills | California | 91345 | - |
| Neurology Offices | Boca Raton | Florida | 33428 | - |
| SFM Clinical Reseach, LLC | Boca Raton | Florida | 33487 | - |
| Homestead Associates in Research | Homestead | Florida | 33033 | - |
| UF Health Jacksonville Respiratory Therapy (PFT and DLCO) | Jacksonville | Florida | 32209 | - |
| Quantix Research | Miami | Florida | 33173 | - |
| Y & L Advance Health Care, Inc D/B/A Elite Clinical Research - Neurology | Miami | Florida | 33144 | - |
| Hawaii Pacific Neuroscience | Honolulu | Hawaii | 96817 | - |
| HSHS Medical Group - St. Elizabeth's Hospital | O'Fallon | Illinois | 62269 | - |
| Las Vegas Neurology Center | Las Vegas | Nevada | 89106 | - |
| Clinical Trials of South Carolina - Neurology | Charleston | South Carolina | 29406 | - |
| Ut Erlanger Neurology | Chattanooga | Tennessee | 37403 | - |
| Nerve and Muscle Center of Texas - Neurology | Houston | Texas | 77030 | - |
| Texas Institute for Neurological Disorders | Sherman | Texas | 75093 | - |
| Neurology Care Clinic | Waxahachie | Texas | 75165 | - |
Find similar trials in Mission Hills, CA
By research site
Related Studies
- Study of Aritinercept in Patients With Generalized Myasthenia GravisPHASE1/PHASE2 · Recruiting · Aurinia Pharmaceuticals Inc. · Pasadena, California
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruiting · Brain Inflammation Collaborative · Delafield, Wisconsin
- Myasthenia Gravis Foundation of America Global MG Patient RegistryRecruiting · Myasthenia Gravis Foundation of America · Westborough, Massachusetts
- Multi-Modal Monitoring of Disease Symptoms in Myasthenia GravisNot Yet Recruiting · BioSensics · Boston, Massachusetts